دورية أكاديمية
The Evolution and Application of a Novel DNA Aptamer Targeting Bone Morphogenetic Protein 2 for Bone Regeneration.
العنوان: | The Evolution and Application of a Novel DNA Aptamer Targeting Bone Morphogenetic Protein 2 for Bone Regeneration. |
---|---|
المؤلفون: | Liu M; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China., Kinghorn AB; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China., Wang L; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China., Bhuyan SK; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China., Shiu SC; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China., Tanner JA; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Advanced Biomedical Instrumentation Centre, Hong Kong Science Park, Shatin, New Territories, Hong Kong SAR, China. |
المصدر: | Molecules (Basel, Switzerland) [Molecules] 2024 Mar 11; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 11. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI, c1995- |
مواضيع طبية MeSH: | Bone Morphogenetic Protein 2*/pharmacology , Bone Morphogenetic Protein 2*/chemistry , Aptamers, Nucleotide*/pharmacology, Humans ; Tissue Scaffolds/chemistry ; Molecular Docking Simulation ; Bone Regeneration ; Transforming Growth Factor beta/pharmacology ; Recombinant Proteins/chemistry |
مستخلص: | Recombinant human bone morphogenetic protein 2 (rhBMP-2) is an FDA-approved growth factor for bone regeneration and repair in medical practice. The therapeutic effects of rhBMP-2 may be enhanced through specific binding to extracellular matrix (ECM)-like scaffolds. Here, we report the selection of a novel rhBMP-2-specific DNA aptamer, functionalization of the aptamer in an ECM-like scaffold, and its application in a cellular context. A DNA aptamer BA1 was evolved and shown to have high affinity and specificity to rhBMP-2. A molecular docking model demonstrated that BA1 was probably bound to rhBMP-2 at its heparin-binding domain, as verified with experimental competitive binding assays. The BA1 aptamer was used to functionalize a type I collagen scaffold, and fraction ratios were optimized to mimic the natural ECM. Studies in the myoblast cell model C2C12 showed that the aptamer-enhanced scaffold could specifically augment the osteo-inductive function of rhBMP-2 in vitro. This aptamer-functionalized scaffold may have value in enhancing rhBMP-2-mediated bone regeneration. |
References: | Proc Inst Mech Eng H. 2010 Dec;224(12):1329-43. (PMID: 21287823) Phys Chem Chem Phys. 2015 Feb 14;17(6):4750-6. (PMID: 25589467) ACS Appl Mater Interfaces. 2018 Mar 14;10(10):8546-8554. (PMID: 29465230) Int J Biol Macromol. 2020 Oct 15;161:1127-1139. (PMID: 32561285) N Engl J Med. 2002 Dec 12;347(24):1924-31. (PMID: 12477942) Nat Protoc. 2010 May;5(5):883-97. (PMID: 20431534) Methods Mol Biol. 2016;1490:199-215. (PMID: 27665601) J Biotechnol. 2019 Dec 20;306:1-8. (PMID: 31075298) J Cell Biol. 1994 Dec;127(6 Pt 1):1755-66. (PMID: 7798324) Adv Healthc Mater. 2015 Jan 7;4(1):131-141. (PMID: 24753455) Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):15967-72. (PMID: 24043813) Biochem Biophys Res Commun. 2008 Feb 8;366(2):420-5. (PMID: 18068116) Trends Biotechnol. 2013 Mar;31(3):169-76. (PMID: 23298610) ACS Appl Mater Interfaces. 2019 May 22;11(20):18123-18132. (PMID: 31026135) ACS Biomater Sci Eng. 2020 Jan 13;6(1):213-218. (PMID: 33463189) Proc Natl Acad Sci U S A. 2022 Mar 22;119(12):e2119945119. (PMID: 35290115) Am J Physiol Endocrinol Metab. 2006 Oct;291(4):E817-28. (PMID: 16735448) Langmuir. 2021 Aug 3;37(30):9043-9052. (PMID: 34279112) Nat Biotechnol. 2005 Jan;23(1):47-55. (PMID: 15637621) Int J Biol Sci. 2008 Feb 03;4(1):37-47. (PMID: 18274622) Protein Expr Purif. 2006 Apr;46(2):374-8. (PMID: 16298141) Int J Pharm. 2022 Jan 25;612:121352. (PMID: 34883207) ACS Appl Mater Interfaces. 2021 Mar 3;13(8):9500-9519. (PMID: 32603135) Biomacromolecules. 2008 Jan;9(1):21-8. (PMID: 18052128) Spine J. 2014 Mar 1;14(3):552-9. (PMID: 24412416) Biomaterials. 2010 Mar;31(7):1875-84. (PMID: 19926126) Front Med (Lausanne). 2020 Oct 22;7:456. (PMID: 33195288) J Bone Joint Surg Am. 2006 Jul;88(7):1431-41. (PMID: 16818967) J Cell Sci. 2008 Feb 1;121(Pt 3):255-64. (PMID: 18216330) Wound Repair Regen. 2010 Jan-Feb;18(1):114-22. (PMID: 20082684) Bioact Mater. 2021 Apr 24;6(11):4163-4175. (PMID: 33997500) Nat Rev Dis Primers. 2021 Aug 5;7(1):57. (PMID: 34354083) Plast Reconstr Surg. 2021 Feb 1;147(2):386-397. (PMID: 33235044) Mater Sci Eng C Mater Biol Appl. 2021 Jan;120:111683. (PMID: 33545845) Nucleic Acids Res. 2003 Jul 1;31(13):3406-15. (PMID: 12824337) Sci Adv. 2021 Jun 11;7(24):. (PMID: 34117071) Eur J Biochem. 1996 Apr 1;237(1):295-302. (PMID: 8620887) Int J Pharm. 1999 Sep 30;187(1):91-9. (PMID: 10502616) J Orthop Trauma. 2019 Apr;33(4):203-213. (PMID: 30633080) Eur J Cell Biol. 2007 Dec;86(11-12):747-61. (PMID: 17651862) J Mol Biol. 1999 Mar 19;287(1):103-15. (PMID: 10074410) Biochemistry. 2004 Dec 28;43(51):15996-6010. (PMID: 15609994) J Periodontal Res. 2002 Oct;37(5):340-4. (PMID: 12366856) Int J Biol Macromol. 2005 Sep 28;36(5):324-6. (PMID: 16111743) Bioengineering (Basel). 2019 Aug 31;6(3):. (PMID: 31480458) Sci Transl Med. 2019 Apr 24;11(489):. (PMID: 31019025) J Am Chem Soc. 2005 Feb 2;127(4):1193-200. (PMID: 15669858) J Biomater Sci Polym Ed. 2013;24(6):645-62. (PMID: 23565907) Biomaterials. 2013 Jan;34(2):452-9. (PMID: 23099062) Mater Sci Eng C Mater Biol Appl. 2014 Dec;45:690-7. (PMID: 25491878) Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110893. (PMID: 32409051) Tissue Eng Part B Rev. 2017 Jun;23(3):268-280. (PMID: 27846781) Nat Rev Endocrinol. 2014 Oct;10(10):592-602. (PMID: 25091729) |
معلومات مُعتمدة: | 17102318 Hong Kong University Grants Council (UGC) General Research Fund (GRF) |
فهرسة مساهمة: | Keywords: BMP-2; DNA aptamer; bone regeneration; collagen scaffold; regenerative medicine |
المشرفين على المادة: | 0 (Bone Morphogenetic Protein 2) 0 (Aptamers, Nucleotide) 0 (Transforming Growth Factor beta) 0 (Recombinant Proteins) |
تواريخ الأحداث: | Date Created: 20240328 Date Completed: 20240329 Latest Revision: 20240330 |
رمز التحديث: | 20240330 |
مُعرف محوري في PubMed: | PMC10974264 |
DOI: | 10.3390/molecules29061243 |
PMID: | 38542880 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1420-3049 |
---|---|
DOI: | 10.3390/molecules29061243 |